← Eichor
Study identifier: NCT07378956 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

Condition: Diabetic Retinopathy (DR) · Diabete Mellitus · Fundus Photography  ·  Sponsor: VUNO Inc.

PhaseNA
Planned participants340
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO Med®-Fundus AI™) alongside routine clinical practice for the detection of diabetic retinopathy.

This description comes directly from the study's public registry record.

Talk to the study team

Hee Jun Park  ·  82-10-7101-2844  ·  heejun.park@vuno.co

Always discuss trial participation with your own doctor first.

Locations (1)

Inha University HospitalIncheon, Gyeonggi-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07378956